Why Is Neurodegenerative Disease-Focused Alterity Therapeuti

Alterity Therapeutics Inc (NASDAQ: ATHE) shares are trading higher after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's 

Related Keywords

David Stamler , , Disease Conference , Chief Executive Officer , Parkinson Behavior Rating Scale ,